Google's Open-Source Gemma Enters the Fray — Now Who's the "CloseAI"? | BlueRun Ventures
The Open-Source LLM Crown Changes Hands
Articles
AI Essential Reading: The Bitter Lesson | 5Y View
The most important lesson learned in AI research over the past 70 years.
Back to Reality! Sora Breaks Through — 4 Key Questions We're Watching | Yunqi FutureScope
Creating Virtual Worlds, Returning to Real-World Problems
How Many Steps Until eVTOL Takes Off? | BlueRun Ventures Headlines
The fundamental challenge of developing an eVTOL is building a proper aircraft first.
ProfoundBio Closes $112 Million Series B to Advance ADC Drug Candidates Into Pivotal Clinical Development
Delivering breakthrough therapies for cancer patients.
VBData Exclusive | Dalton Venture: The Next Phase of Opportunities in Healthcare — "Technology + Safety" Is the Unavoidable Theme
In a turbulent environment, most investment firms have chosen to play it safe, pulling back on deal activity. Yet in 2023 — widely called a funding winter — Dalton Venture actually picked up its investment pace. How does the firm see 2024 shaping up? At the start of the new year, Sun Qi, founding and managing partner of Dalton Venture, sat down with VBData to share his outlook on healthcare trends for 2024 and his advice for founders.
After Reading 100,000 Words of Sora Discussions, Here Are 6 Takeaways I Want to Share
"I used to not believe it was real. Now I don't believe it's fake."
Here are 17 industry research reports and a podcast episode to get you started — happy first day back at work.
How do we embrace the changes that lie ahead?
Hello, Doers | Yunqi Capital's Lunar New Year Message for the Year of the Dragon
Enduring through nine years, ever renewed; stepping into the tenth, forging ahead.
Riding the dragon to the clouds — wishing you the same, and wishing it for me too | Red Packet Covers: Wave Two
Missed the BlueRun Ventures Chenglong Youth red packet covers? There are still some here!